GO:0045236 CXCR chemokine receptor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045236 defines the molecular function of binding to a chemokine receptor in the CXCR family, including CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, and the atypical receptor ACKR3 [1,2,3,4].
• CXC chemokines such as CXCL8 (IL-8) and CXCL12 act as endogenous ligands for CXCR receptors, and their binding triggers receptor activation, conformational changes, and downstream signaling [2,4].
• Phosphorylation barcodes on the receptor C-terminal tail regulate arrestin recruitment and bias signaling outcomes, a key mechanism for CXCR chemokine receptor binding specificity [1,8].
• Atypical chemokine receptor 3 (ACKR3) senses CXCR4 activation through GPCR kinase phosphorylation, illustrating cross-talk between CXCR family members.
• Membrane bilayer lipids modulate ligand binding to ACKR3, showing that the lipid environment is a critical determinant of CXCR chemokine receptor binding.
• Dysregulated CXCR chemokine receptor binding is implicated in cancer, fibrosis, and age-related liver disease, making it a target for therapeutic intervention [5,7].
Description
GO:0045236, CXCR chemokine receptor binding, is a molecular function term that describes the binding of a ligand to a chemokine receptor belonging to the CXCR family [1,2]. This function is central to chemokine signaling, which controls leukocyte trafficking, immune surveillance, and tissue homeostasis. The CXCR family includes receptors such as CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, and the atypical receptor ACKR3, all of which interact with CXC chemokines like CXCL8 and CXCL12 [2,3,4]. Understanding this binding event is critical because it initiates intracellular signaling cascades that influence cell migration, proliferation, and survival [4,8]. Researchers study CXCR chemokine receptor binding to dissect how specificity is achieved, how receptor activation is regulated, and how dysregulation contributes to disease [1,3,8]. Recent structural and biochemical studies have revealed that phosphorylation barcodes on receptor tails and membrane lipid composition fine-tune ligand binding and downstream responses [1,3]. These insights are essential for developing targeted therapies that modulate chemokine receptor activity in cancer, fibrosis, and inflammatory conditions [5,7].
CXCR chemokine receptor binding At A Glance
| GO ID | GO:0045236 |
|---|---|
| GO term | CXCR chemokine receptor binding |
| Ontology | molecular_function |
| Synonym | alpha chemokine receptor binding; alpha chemokine receptor ligand; C-X-C chemokine receptor ligand; CXC chemokine receptor ligand |
| Major function | Binding to chemokine receptors of the CXCR family, initiating or modulating intracellular signaling [1,2] |
| Major ligands | CXC chemokines such as CXCL8 (IL-8), CXCL12, and others [2,4] |
| Major receptors | CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, ACKR3 [2,3,4,8] |
| Regulatory mechanism | Phosphorylation barcodes on receptor C-terminal tails and membrane lipid composition [1,3,8] |
What Is GO:0045236?
CXCR chemokine receptor binding is the molecular function of selectively interacting with a chemokine receptor in the CXCR family. This binding event is non-covalent and typically occurs between a CXC chemokine ligand and the extracellular domains of the receptor, leading to receptor activation or modulation [1,2,3]. The term encompasses binding to both conventional signaling receptors (e.g., CXCR4) and atypical receptors (e.g., ACKR3) that can sequester or scavenge chemokines [3,4,8].
Why Is CXCR chemokine receptor binding Important in Cell Biology?
CXCR chemokine receptor binding is a fundamental molecular event that governs immune cell recruitment, tissue repair, and cancer progression [2,5,7]. Dysregulation of this binding function can lead to chronic inflammation, fibrosis, and tumor metastasis, making it a high-value target for drug discovery [5,7]. Understanding the structural and biochemical basis of this interaction is essential for designing inhibitors or modulators that can selectively block or enhance specific chemokine-receptor pairs [1,6].
• Controls leukocyte trafficking and immune surveillance through chemokine gradients.
• Regulates angiogenesis and endothelial repair in lung and liver tissues [5,7].
• Implicated in cancer metastasis, where CXCR4 and ACKR3 promote tumor cell migration [4,8].
• Modulates fibrotic responses in pulmonary and hepatic tissues [5,7].
• Phosphorylation barcodes on receptors determine arrestin recruitment and signaling bias [1,8].
• Membrane lipids influence ligand binding affinity and receptor conformation.
• Atypical receptors like ACKR3 scavenge chemokines and shape gradient formation [3,4].
• Targeted modulation of CXCR binding can reduce inflammation and fibrosis in preclinical models [5,7].
• Conformational restriction strategies are used to develop follow-on drugs targeting chemokine receptors.
• Age-related changes in endothelial CXCR signaling contribute to steatohepatitis.
Molecular Mechanism of CXCR chemokine receptor binding
Ligand recognition and initial binding
In simple terms: The chemokine ligand first docks onto the receptor's extracellular surface.
CXC chemokines such as CXCL8 bind to the N-terminal domain and extracellular loops of CXCR receptors through electrostatic and hydrophobic interactions. This initial docking is reversible and can be influenced by the lipid bilayer composition surrounding the receptor. For ACKR3, bilayer lipids modulate ligand binding by altering receptor conformation and accessibility.
Conformational changes and receptor activation
In simple terms: Binding causes the receptor to change shape, turning on signaling inside the cell.
Upon ligand binding, CXCR receptors undergo conformational rearrangements that propagate from the ligand-binding pocket to the intracellular G-protein coupling interface. These dynamics are essential for activation and are regulated by phosphorylation of the receptor C-terminal tail [1,4]. Phosphorylation barcodes create distinct arrestin-binding interfaces that bias downstream signaling.
Phosphorylation barcodes and arrestin recruitment
In simple terms: Phosphate tags on the receptor act like a code that tells arrestin where to bind.
GPCR kinases phosphorylate specific serine and threonine residues on the CXCR receptor tail, forming a barcode that dictates arrestin binding affinity and orientation [1,8]. This barcode mechanism allows the same receptor to activate different signaling pathways depending on the phosphorylation pattern. ACKR3 senses CXCR4 activation through such phosphorylation events, demonstrating inter-receptor regulation.
Atypical receptor function and scavenging
In simple terms: Some CXCR-family receptors do not signal but instead soak up chemokines.
ACKR3 is an atypical chemokine receptor that binds CXC chemokines but does not couple to G proteins; instead, it internalizes and degrades ligands, shaping chemokine gradients [3,4]. Its binding activity is modulated by membrane lipids and phosphorylation, which affect its conformational dynamics [3,4]. This scavenging function is critical for controlling CXCR4-mediated signaling in development and disease.
Regulation by membrane environment and cofactors
In simple terms: The cell membrane's fat composition can change how well chemokines stick to receptors.
Bilayer lipids such as cholesterol and phospholipids modulate ligand binding to ACKR3 by altering receptor dynamics and ligand accessibility. This lipid-dependent regulation adds another layer of control beyond protein-protein interactions. Additionally, conformational restriction strategies in drug discovery exploit these binding nuances to design selective modulators.
Key Genes Involved in GO:0045236 CXCR chemokine receptor binding
The following genes encode chemokines, receptors, and regulatory proteins directly involved in CXCR chemokine receptor binding.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL8 | Primary ligand for CXCR1 and CXCR2 | Inflammation and cancer progression |
| CXCL12 | Ligand for CXCR4 and ACKR3 | Stem cell homing and metastasis [4,8] |
| CXCR1 | Receptor for CXCL8 | Neutrophil recruitment |
| CXCR2 | Receptor for CXCL8 and other CXC chemokines | Angiogenesis and inflammation |
| CXCR3 | Receptor for CXCL9, CXCL10, CXCL11 | Th1 immune responses |
| CXCR4 | Receptor for CXCL12 | Cancer metastasis and HIV entry [4,8] |
| CXCR5 | Receptor for CXCL13 | B cell follicle formation |
| CXCR6 | Receptor for CXCL16 | T cell migration |
| ACKR3 | Atypical receptor for CXCL12 | Chemokine scavenging and gradient shaping [3,4,8] |
| GRK2 | GPCR kinase that phosphorylates CXCR4 | Regulates arrestin recruitment [1,8] |
| GRK3 | GPCR kinase that phosphorylates CXCR4 | Regulates arrestin recruitment [1,8] |
| ARRB1 | Beta-arrestin 1 | Binds phosphorylated receptor tails |
| ARRB2 | Beta-arrestin 2 | Binds phosphorylated receptor tails |
| GNAI1 | G protein alpha subunit | Couples to CXCR4 for signaling |
| GNAI2 | G protein alpha subunit | Couples to CXCR4 for signaling |
| GNAI3 | G protein alpha subunit | Couples to CXCR4 for signaling |
| KIT | Receptor tyrosine kinase | Endothelial zonation and steatohepatitis |
How Is CXCR chemokine receptor binding Regulated?
CXCR chemokine receptor binding is regulated at multiple levels. Phosphorylation of the receptor C-terminal tail by GPCR kinases creates barcodes that determine arrestin binding and signaling bias [1,8]. Membrane lipid composition, including cholesterol and phospholipid content, modulates ligand binding affinity and receptor conformational dynamics. Additionally, atypical receptors like ACKR3 can scavenge chemokines, indirectly regulating the availability of ligands for conventional CXCR receptors [3,4]. Age-related changes in endothelial cells can alter CXCR signaling and contribute to liver disease.
CXCR chemokine receptor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCR4 | Cancer metastasis | Knockout in cancer cell lines [4,8] |
| ACKR3 | Chemokine scavenging in cancer | Point mutation of phosphorylation sites [3,4] |
| CXCL12 | Fibrosis and metastasis | Overexpression in stromal cells |
| CXCL8 | Inflammation and cancer | Knockout in immune cells |
| KIT | Age-related steatohepatitis | Conditional knockout in liver endothelium |
Cancer metastasis and tumor microenvironment
CXCR4 and ACKR3 are overexpressed in many cancers and promote metastasis by binding CXCL12 [4,8]. This binding activates signaling pathways that enhance cell migration and survival. Targeting CXCR chemokine receptor binding is a therapeutic strategy for blocking metastatic spread.
Pulmonary fibrosis and lung injury
CXCR chemokine receptor binding in pulmonary capillary endothelial cells contributes to alveolar repair and fibrosis. Dysregulated binding can lead to excessive fibroblast activation and tissue scarring. Modulating this binding may promote lung regeneration.
Age-related liver steatohepatitis
Age-related liver endothelial zonation triggers steatohepatitis through inactivation of pericentral endothelium-derived C-kit, which is linked to CXCR chemokine receptor binding. This highlights the role of chemokine signaling in metabolic liver disease.
From CXCR chemokine receptor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CXCR4 phosphorylation barcode affect arrestin recruitment? | Point mutation of C-terminal tail serines/threonines |
| What is the role of ACKR3 in chemokine scavenging? | Knockout of ACKR3 in endothelial cells [3,4] |
| How does CXCL12 overexpression affect fibrosis? | Knock-in of CXCL12 in mouse liver |
| Can CXCR4 be tagged for live imaging? | Tagged knock-in of CXCR4 with fluorescent protein |
| Does CXCR2 overexpression drive inflammation? | Overexpression of CXCR2 in transgenic mice |
| What is the impact of GRK2 knockout on CXCR4 signaling? | Knockout of GRK2 in immune cells [1,8] |
How to Study the CXCR chemokine receptor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Ligand-receptor affinity | Screening for inhibitors |
| Surface plasmon resonance | Binding kinetics | Characterizing chemokine-receptor interactions |
| Cryo-EM | Receptor conformation | Structural basis of binding [1,4] |
| Phospho-specific Western blot | Receptor phosphorylation | Arrestin recruitment studies [1,8] |
| CRISPR knockout screen | Gene function in binding | Identifying regulators [5,7] |
| Live-cell imaging | Receptor trafficking | Internalization and scavenging |
| Proteomics | Protein interactions | Mapping signaling complexes |
| RNA-seq | Gene expression changes | Downstream transcriptional responses |
Biochemical binding assays
Radioligand binding and surface plasmon resonance (SPR) measure the affinity and kinetics of chemokine-receptor interactions [2,3]. These methods are used to screen for inhibitors or modulators of CXCR chemokine receptor binding.
Structural biology and conformational analysis
Cryo-EM and X-ray crystallography reveal the structural basis of ligand binding and receptor activation [1,4]. These techniques help map phosphorylation barcodes and lipid interactions [1,3].
Phosphorylation and signaling assays
Western blotting with phospho-specific antibodies detects receptor phosphorylation and arrestin recruitment [1,8]. These assays are used to study signaling bias and regulation.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens identify genes that regulate CXCR chemokine receptor binding and downstream signaling [5,7]. These screens can uncover novel therapeutic targets.
How CRISPR Can Be Used to Study GO:0045236 CXCR chemokine receptor binding
Knockout
CRISPR knockout of CXCR4, ACKR3, or their ligands can abolish CXCR chemokine receptor binding and reveal loss-of-function phenotypes in immune cells and cancer models [4,5,7]. Knockout of GRK2 or GRK3 can prevent receptor phosphorylation and arrestin recruitment [1,8].
Point Mutation
Point mutations of specific serine or threonine residues in the CXCR4 C-terminal tail can disrupt phosphorylation barcodes, altering arrestin binding and signaling bias. Such models are essential for dissecting the role of individual phosphorylation sites.
Knock-in
Knock-in of tagged CXCR4 or ACKR3 allows live-cell imaging and tracking of receptor trafficking and ligand binding. Knock-in of disease-associated mutations can model human disorders linked to chemokine receptor dysfunction.
Overexpression
Overexpression of CXCL12 or CXCR4 in transgenic models can drive fibrosis, inflammation, or metastasis, providing insights into gain-of-function mechanisms [2,7]. Overexpression of ACKR3 can enhance chemokine scavenging and modulate gradient formation [3,4].
How EDITGENE Supports CXCR chemokine receptor binding Research
Researchers studying CXCR chemokine receptor binding-related genes often need to determine whether a candidate gene is causally involved in ligand recognition, receptor activation, or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for CXCR chemokine receptor binding research.
Frequently Asked Questions About CXCR chemokine receptor binding
What is CXCR chemokine receptor binding?
CXCR chemokine receptor binding is the molecular function of binding to a chemokine receptor in the CXCR family, as defined by GO:0045236 [1,2].
What genes are involved in CXCR chemokine receptor binding?
Key genes include CXCL8, CXCL12, CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, ACKR3, GRK2, GRK3, ARRB1, and ARRB2 [1,2,3,4,8].
How is CXCR chemokine receptor binding regulated?
It is regulated by phosphorylation barcodes on receptor tails, GPCR kinases, arrestins, and membrane lipid composition [1,3,8].
What diseases are associated with CXCR chemokine receptor binding?
It is linked to cancer metastasis, pulmonary fibrosis, and age-related liver steatohepatitis [4,5,7].
What is the role of ACKR3 in CXCR chemokine receptor binding?
ACKR3 is an atypical receptor that binds CXC chemokines and scavenges them, shaping chemokine gradients [3,4,8].
How can I study CXCR chemokine receptor binding in the lab?
Common methods include radioligand binding assays, surface plasmon resonance, cryo-EM, phospho-specific Western blotting, and CRISPR screens [1,2,3,5].
What CRISPR models are available for CXCR chemokine receptor binding?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like CXCR4, ACKR3, and CXCL12 [1,4,5,7].
Why is CXCR4 important in cancer?
CXCR4 binds CXCL12 and promotes metastasis by activating migration and survival pathways [4,8].
What is a phosphorylation barcode in CXCR signaling?
It is a pattern of phosphorylation on the receptor C-terminal tail that determines arrestin binding and signaling bias [1,8].
How do membrane lipids affect CXCR chemokine receptor binding?
Bilayer lipids modulate ligand binding to ACKR3 by altering receptor conformation and accessibility.
Conclusion
CXCR chemokine receptor binding (GO:0045236) is a critical molecular function that governs immune cell trafficking, tissue repair, and cancer progression. Recent advances have revealed the importance of phosphorylation barcodes, membrane lipids, and atypical receptors in fine-tuning this binding event [1,3,4,8]. Targeting this function holds promise for treating fibrosis, cancer, and inflammatory diseases [5,7]. EDITGENE offers a full suite of CRISPR services to help researchers dissect the mechanisms and therapeutic potential of CXCR chemokine receptor binding.
References
- 1. Chen Q et al.. 2025. Effect of phosphorylation barcodes on arrestin binding to a chemokine receptor.. Nature 643(8070):280-287 PMID: 40399676
- 2. Matsushima K et al.. 2022. Interleukin-8: An evolving chemokine.. Cytokine 153:155828 PMID: 35247648
- 3. Eberle SA et al.. 2024. Bilayer lipids modulate ligand binding to atypical chemokine receptor 3.. Structure 32(8):1174-1183.e5 PMID: 38776922
- 4. Otun O et al.. 2024. Conformational dynamics underlying atypical chemokine receptor 3 activation.. Proc Natl Acad Sci U S A 121(30):e2404000121 PMID: 39008676
- 5. Duan JL et al.. 2023. Age-related liver endothelial zonation triggers steatohepatitis by inactivating pericentral endothelium-derived C-kit.. Nat Aging 3(3):258-274 PMID: 37118422
- 6. Fang Z et al.. 2014. Conformational restriction: an effective tactic in 'follow-on'-based drug discovery.. Future Med Chem 6(8):885-901 PMID: 24962281
- 7. Cao Z et al.. 2016. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis.. Nat Med 22(2):154-62 PMID: 26779814
- 8. Schafer CT et al.. 2023. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.. Mol Pharmacol 104(4):174-186 PMID: 37474305
